Company news
Rallybio Corporation news in 2021
Rallybio Corporation's news releases, calls and decks from 2021, newest first.
Rallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
November 30, 2021
Rallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business Highlights
November 9, 2021
Rallybio Corporation Reports Second Quarter 2021 Financial Results and Recent Business Highlights
September 8, 2021
Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
August 1, 2021
Rallybio Corporation Announces Pricing of Initial Public Offering
July 27, 2021